Lazard Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.8M | Buy |
|
|||||
2025
Q1 | $2.94M | Sell |
|
|||||
2024
Q4 | $3.73M | Buy |
|
|||||
2024
Q3 | $2.76M | Buy |
|
|||||
2024
Q2 | $3.79M | Buy |
|
|||||
2024
Q1 | $4.5M | Sell |
|
|||||
2023
Q4 | $5.83M | Buy |
|
|||||
2023
Q3 | $4.32M | Sell |
|
|||||
2023
Q2 | $6.06M | Buy |
|
|||||
2023
Q1 | $5.39M | Sell |
|
|||||
2022
Q4 | $8.81M | Sell |
|
|||||
2022
Q3 | $11M | Buy |
|
|||||
2022
Q2 | $10.1M | Buy |
|
|||||
2022
Q1 | $11.4M | Buy |
|
|||||
2021
Q4 | $9.9M | Buy |
|
|||||
2021
Q3 | $6.91M | Sell |
|
|||||
2021
Q2 | $6.08M | Buy |
|
|||||
2021
Q1 | $575K | Buy |
|
|||||
2020
Q4 | $429K | Buy |
|
|||||
2020
Q3 | $433K | Hold |
|
|||||
2020
Q2 | $426K | Buy |
|
|||||
2020
Q1 | $21K | Buy |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $524K | Sell |
|
|||||
2019
Q2 | $832K | Hold |
|
|||||
2019
Q1 | $661K | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $1.05M | Buy |
|
|||||
2015
Q3 | – | Sell |
|
|||||
2015
Q2 | $71K | Buy |
|
|||||
2015
Q1 | $50K | Buy |
|
|||||
2014
Q4 | $4K | Hold |
|
|||||
2014
Q3 | $3K | Buy |
|